Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Jeju National University Industry-Academic Cooperation Foundation is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are being handled by 2 distinct examiners. Despite the involvement of multiple examiners, the prosecution is contained within 1 distinct art unit, suggesting a consistent technical focus for the foundation's current applications.
PACHECO, ALEXIS BOATENG is the busiest examiner for the foundation, with 1 pending office action. Since there are 2 pending office actions in total, the workload is evenly divided between the 2 distinct examiners. The fact that both examiners are located within 1 distinct art unit suggests that the technical review is being conducted by a specific specialized group at the USPTO, which may lead to similar examination styles or internal policy applications.
Practitioners should observe that while the foundation interacts with 2 distinct examiners, the shared art unit provides a centralized technical environment. The 2 pending office actions represent the total active challenges for the portfolio. With 1 pending office action assigned to the busiest examiner, the foundation must coordinate two separate responses within a single technical division. This requires a balanced approach to satisfy the requirements of PACHECO, ALEXIS BOATENG and the other assigned examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PACHECO, ALEXIS BOATENG | 1 | 77.7% | +12.6% |
| BAEK, BONG-SOOK | 1 | 41.7% | +69.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18321965 | COMPOSITION FOR PREVENTING OR TREATING BREAST CANCER COMPRISING COMPOUND DERIVED FROM DENDROPANAX MORBIFERUS | BAEK, BONG-SOOK | 22d overdue |
| 18285191 | APPARATUS AND METHOD FOR CHARGING WIRELESSLY OF A VEHICLE BATTERY | PACHECO, ALEXIS BOATENG | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18285191 | APPARATUS AND METHOD FOR CHARGING WIRELESSLY OF A VEHICLE BATTERY | PACHECO, ALEXIS BOATENG | — | §103 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18321965 | COMPOSITION FOR PREVENTING OR TREATING BREAST CANCER COMPRISING COMPOUND DERIVED FROM DENDROPANAX MORBIFERUS | BAEK, BONG-SOOK | 1611 | §103 | Non-Final OA | 22d overdue | Pending | May 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial